Evidence and triggers for the transfusion of blood and blood products

Anaesthesia

Volumn 70, Issue S1, 2015, Pages 10-19

  Shah, A ^a   Stanworth, S J ^a   McKechnie, S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HUMAN; PREOPERATIVE CARE; THROMBOCYTE TRANSFUSION;

ANEMIA; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HUMANS; PLATELET TRANSFUSION; PREOPERATIVE CARE;

EID: 84925081044     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12893     Document Type: Review

References (86)

1. Takei T, Amin NA, Schmid G, Dhingra-Kumar N, Rugg D. Pro-gress in global blood safety for HIV. Journal of Acquired Immune Deficiency Syndromes 2009; 52: S127–31.
2. Bolton-Maggs PHB (Ed), Cohen H; on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report. 2012. http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/(accessed 13/06/2014).
3. Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the Anaesthetist. Red Cell Transfusion 2. London: AAGBI, 2008.
4. Kulvatonyou N, Heard SO. Care of the injured Jehovah’s Wit-ness patient: case report and review of the literature. Journal of Clinical Anesthesiology 2004; 16: 548–53.
5. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe, isovolemic anemia. Journal of the American Medical Association 1998; 279: 217–21.
6. Carson JL, Grossman BJ, Klelnman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2012; 157: 49–58.
7. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. New England Journal of Medicine 2008; 358: 1229–39.
8. Bakker J, Vincent JL. The oxygen supply dependency phenom-enon is associated with increased blood lactate levels. Journal of Critical Care 1991; 6: 152–9.
9. Gilbert EM, Haupt MT, Mandanas RY, Huaringa AJ, Carlson RW. The effect of fluid loading, blood transfusion and catechol-amine infusion on oxygen delivery and consumption in patients with sepsis. American Review of Respiratory Disease 1986; 134: 873–8.
10. Spahn DR, Theusinger OM, Hofmann A. Patient blood management is a win-win: a wake up call. British Journal of Anaesthesia 2012; 108: 889–92.
11. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Ange-lini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac sur-gery. Circulation 2007; 116: 2544–52.
12. Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establish-ing causation. Transfusion Medicine Reviews 2011; 25: 89– 101.
13. Carson JL, Carless PA, Herbert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfu-sion. Cochrane Database of Systematic Reviews 2012; 4: CD002042.
14. Carson JL, Carless PA, Herbert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. Journal of the American Medical Association 2013; 309: 83–4.
15. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflam-matory response, immunomodulation and cancer recurrence after perioperative blood transfusions. British Journal of Anaesthesia 2013; 110: 690–701.
16. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database of Systematic Reviews 2006; 1: CD005033.
17. Rohde JM, Dimcheff DE, Blumberg N, et al. Healthcare-associ-ated infection after red blood cell transfusion: a systematic review and meta-analysis. Journal of the American Medical Association 2014; 311: 1317–26.
18. de Benoist B, McLean E, Egli I, Cogswell M, eds. Worldwide Prevalence of Anaemia 1993–2005. Geneva: World Health Organisation, 2008.
19. Shander A, Knight K, Thurer R, Adamson J. Prevalence and outcomes of anaemia in surgery: a systematic review of the literature. American Journal of Medicine 2004; 116: 58S–69S.
20. Shander A, Javidroozi M, Ozawa S, Hare GMT. What is really dangerous? Anaemia or transfusion? British Journal of Anaesthesia 2011; 107: i41–9.
21. Musallam KM, Tamim HM, Richards T, et al. Pre-operative anaemia and post-operative outcomes in non-cardiac surgery. Lancet 2011; 378: 1396–407.
22. Cappell MS, Goldberg ES. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: a significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. Journal of Clinical Gastroenterology 1992; 14: 227–35.
23. Saleh E, McClelland DB, Hay A, Semple D, Walsh TS. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. British Journal of Anaesthesia 2007; 99: 801–8.
24. Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. British Journal of Anaesthesia 2012; 108: 943–52.
25. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482–95.
26. Vincent JL, Baron JF, Reinhart K, et al. Anaemia and blood transfusion in critically ill patients. Journal of the American Medical Association 2002; 288: 1499–507.
27. Gombotz H, Rehak PH, Shander A, Hoffman A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468–80.
28. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anaemia in noncardiac surgery: a sin-gle-center cohort study. Anaesthesiology 2009; 110: 574–81.
29. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anaemia in persons 65 years and older in the United States: evidence for a high rate if unexplained anaemia. Blood 2004; 104: 2263–8.
30. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. British Journal of Anaesthesia 2008; 100: 599–604.
31. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A. Iron metabolism and erythropoiesis after surgery. British Journal of Surgery 1998; 85: 41–5.
32. Nemeth E. Anti-hepcidin therapy for iron-restricted anaemias. Blood 2013; 122: 2929–31.
33. World Health Organization Blood Transfusion Safety. Clinical Use of Blood Handbook. Geneva, Switzerland: World Health Organization, 2001.
34. Burke ZD, Chen JB, Conciecao C, et al. Evaluation of preoperative and intraoperative transfusion practices at Maputo Central Hospital, Mozambique. Transfusion 2014; 54: 42–8.
35. British Committee for Standards in Haematology. Guidelines for the clinical use of red cell transfusions. British Journal of Haematology 2001; 113: 24–31.
36. Patel MS, Carson JL. Anemia in the preoperative patient. Medical Clinics of North America 2009; 93: 1095–104.
37. Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews 2012; 1: CD003149.
38. Pearse RM, Harrison DA, MacDonald N, et al. Effect of a peri-operative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery. Journal of the American Medical Association 2014; 311: 2181–90.
39. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine 2001; 345: 1368–77.
40. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Cam-paign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013; 39: 165–228.
41. Yealy DM, Kellum JA, Huang DT. A randomized protocol-based care for early septic shock. New England Journal of Medicine 2014; 370: 1683–93.
42. Rowan K. The Clinical and Cost-effectiveness of Early, Goal-directed, Protocolised Resuscitation for Emerging Septic Shock. ISRCTN 36307479. UKCRN ID 5338. http://public.ukcrn. org.uk/Search/StudyDetail.aspx?StudyID=9820(accessed 13/06/2014).
43. Australasian Resuscitation in Sepsis Evaluation Randomised Controlled Trial (ARISE). http://clinicaltrials.gov/show/NCT009 75793 (accessed 13/06/2014).
44. Stanworth SJ. The evidence-based use of FFP and cryoprecipi-tate for abnormalities of coagulation tests and clinical coagul-opathy. Haematology 2007; 2007: 179–86.
45. BCSH. Guidelines for the use of fresh frozen plasma. British Journal of Haematology 2004: 126: 11–28.
46. Hoffman M, Monroe DM. A cell-based model of haemostasis. Thrombosis & Haemostasis 2001; 21: 958–65.
47. Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests of near-patient assessments with clinical judgment in the management of bleeding after cardiac surgery. British Journal of Anaesthesia 2004; 92: 178–86.
48. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence based review. Transfusion 2005; 45: 1413–25.
49. Deitcher SR. Interpretation of the international normalized ratio in patients with liver disease. Lancet 2002; 359: 47–8.
50. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesthesia and Analgesia 2008; 106: 1366–75.
51. Stanworth SJ, Grant-Casey J, Lowe D, et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51: 62–70.
52. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52: 1673–86.
53. Stanworth S, Walsh T, Prescott R, et al. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Critical Care 2011; 15: R108.
54. Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion 2012; 52(Suppl 1): 65S–79S.
55. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfu-sions. British Journal of Haematology 2003; 122: 10–23.
56. http://www.transfusion.com.au/blood_products/components/platelets/use (accessed 13/06/2014).
57. Lieberman L, Bercovitz RS, Sholapur NS, Heddle NM, Stan-worth SJ, Arnold DM. Platelet transfusions in critically ill patients with thrombocytopenia. Blood 2014; 123: 1146–51.
58. http://hospital.blood.co.uk/library/pdf/Platelet_tx_matters. pdf (accessed 13/06/2014).
59. Stanworth SJ, Estcourt LJ, Powter G, et al. The effect of a no-prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized con-trolled, non-inferiority trial. New England Journal of Medicine 2013; 368: 1771–80.
60. Bolton-Maggs PHB (Ed), Poles D, Watt A, Thomas D, Cohen H; on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2012 Annual SHOT Report. 2013. http://www.shot-uk.org/shot-reports/report-summary-and-supplement-2012/(accessed 13/06/2014).
61. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5: 266–73.
62. Wikkelso A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database of Systematic Reviews 2013; 8: CD008864.
63. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing rad-ical cystectomy: a randomised placebo-controlled trial. Journal of Thrombosis and Haemostasis 2009; 7: 795–802.
64. Karlsson M, Ternstrom L, Hyllner M, et al. Prophylactic fibrino-gen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thrombosis and Haemostasis 2009; 102: 137–44.
65. Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010; 65: 1153–61.
66. http://www.transfusionguidelines.org.uk/uk-transfusion-com-mittees/regional-transfusion-committees/audits/audits/cryo-precipitate-for-transfusion-which-patients-receive-it-and-why-a-study-of-patterns-of-use-across-3-regions-north-east-rtc-london-rtc-and-south-central-rtc-feb-2012 (accessed 02/08/2014).
67. Johnson RG, Thurer RL, Kruskall MS, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. Journal of Thoracic and Cardiovascular Surgery 1992; 104: 307–14.
68. Bracey AW, Radovancevic R, Riggs SA, et al. Lower the hemoglobin threshold for transfusion in coronary artery bypass pro-cedures: effect on patient outcome. Transfusion 1999; 39: 1070–7.
69. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery. Journal of the American Medical Association 2010; 304: 1559–67.
70. Reeves B. A Multi-centre Randomised Controlled Trial of Transfusion Indication Threshold Reduction on Transfusion Rates, Morbidity and Healthcare Resource use Following Cardiac Surgery. http://public.ukcrn.org.uk/search/StudyDetail.aspx? StudyID=5338 (accessed 13/06/2014).
71. Bush RL, Pevec WC, Holcroft JW. A prospective randomised controlled trial limiting perioperative red blood cell transfusions in vascular patients. American Journal of Surgery 1997; 174: 143–8.
72. Carson JL, Terrin ML, Barton FB, et al. A pilot randomised controlled trial comparing symptomatic vs. hemoglobin-level dri-ven red blood cell transfusions following hip fracture. Transfusion 1998; 38: 522–9.
73. Grover M, Talwalker SA, Contreras M, Soni N. Blood transfusion threshold and silent myocardial ischaemia after lower limb arthoplasty: a randomised controlled trial of transfusion strategy. Transfusion Alternatives in Transfusion Medicine 2005; 7(Suppl): 62–3.
74. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kelhet M. The effect of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009; 49: 227–34.
75. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine 2011; 365: 2453–62.
76. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury 2013; 44: 1916–8.
77. So-Osman C, Nelissen R, Brand R, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfusion 2013; 11: 289–95.
78. Rossmiller SR, Cannady BS, Ghanem TA, Wax MK. Transfusion criteria in free flap surgery. Otolaryngology Head and Neck Surgery 2010; 142: 359–64.
79. Herbert PC, Wells G, Blajchman MA, et al. A multicenter randomised controlled trial of transfusion requirements in critical care. New England Journal of Medicine 1999; 340: 409–17.
80. Walsh T, Boyd J, Watson D, et al. Restrictive versus liberal transfusion strategies in older mechanically ventilated critically ill patients. Critical Care Medicine 2013; 41: 2354– 63.
81. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013; 368: 11–21.
82. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction. American Journal of Cardiology 2011; 108: 1108–11.
83. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. American Heart Journal 2013; 165: 964–71.
84. Levi M, ten Cate H. Disseminated intravascular coagulation. New England Journal of Medicine 1999; 341: 586–92.
85. Bishop L, Dougherty L, Bodenham A, et al. Guideline on the insertion and management of central venous access devices in adults. International Journal of Laboratory Haematology 2007; 29: 261–78.
86. Association of Anaesthetists of Great Britain and Ireland, Obstetric Anaesthetists’ Association and Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation. Anaesthesia 2013; 68: 966–72.